Logo
x

Search category

Subscribe Now

AstraZeneca

PharmaShots Weekly Snapshots (September 18–22, 2023)

PharmaShots Weekly Snapshots (September 18–22, 2023)

  • September 23, 2023
AstraZeneca and Daiichi Sankyo Receive the EMA’s CHMP Positive Opinion Recommending Approval of Enhertu for HER2-Mutant Advanced NSCLC

AstraZeneca and Daiichi Sankyo Receive the EMA’s CHMP Positive Opinion Recommending Approval of Enhertu for HER2-Mutant Advanced N...

  • September 18, 2023
AstraZeneca Reports P-III Trial (FLAURA2) Results of Tagrisso for EGFR-Mutated Advanced Lung Cancer

AstraZeneca Reports P-III Trial (FLAURA2) Results of Tagrisso for EGFR-Mutated Advanced Lung Cancer

  • September 12, 2023
AstraZeneca and Daiichi Sankyo Report Initial Results from the P-Ib Trial (TROPION-Lung04) of Datopotamab deruxtecan + Imfinzi as 1L Advanced Non-Small Cell Lung Cancer

AstraZeneca and Daiichi Sankyo Report Initial Results from the P-Ib Trial (TROPION-Lung04) of Datopotamab deruxtecan + Imfinzi as...

  • September 11, 2023
AstraZeneca’s Calquence (acalabrutinib) Receives NMPA’s Approval for Chronic Lymphocytic Leukaemia in China

AstraZeneca’s Calquence (acalabrutinib) Receives NMPA’s Approval for Chronic Lymphocytic Leukaemia in China

  • September 4, 2023
AstraZeneca’ Soliris Receives the MHLW Approval for Paediatric Patients with Generalised Myasthenia Gravis

AstraZeneca’ Soliris Receives the MHLW Approval for Paediatric Patients with Generalised Myasthenia Gravis

  • August 24, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.